Cornell Vaginal Ring

Alternative Name: BioRings Intravaginal Ring

Description: A vaginal ring that releases multiple types of non-hormonal agents and microbicides/anti-viral agents, including ferrous gluconate, ascorbic acid, pharmalytes, boclysinated betulonic acid, and tenofovir.

Product Details

User: Female

Hormonal: No

Delivery Method: Vaginal Ring

Duration Type: Short-acting

Duration: 28 days

  • once per month

Active Pharmaceutical Ingredient (API):
  • tenofovir
  • ascorbic acid
  • ferrous gluconate
  • boclysinated betulonic acid

Inactive material: nanoporous elastomere hydrogel

Multipurpose Preventive Technology (MPT): Yes

Status Details

Developer: BioRings, Weill Cornell Medical College, QPharma

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Pre-clinical

Active Development: No

Status Details:
  • No published updates since 2015. No longer listed on iMPT database. No other technologies in development appear to be a continuation of this product.

Additional Information


Vertical Tabs